2773 results found
MRFF – Cardiovascular Health Mission - 2024 Cardiovascular Health Grant Opportunity
When working with research that involves human embryos created by assisted reproductive technology (ART), it can be difficult to determine if a licence is required for training and quality assurance activities. The attached documents provide information and helpful links to help identify legislative requirements.
Leukaemias are difficult-to-treat blood cancers, which are common among both young and older people. In Australia in 2023, around 20,000 people were diagnosed with a blood cancer and blood cancers accounted for an estimated 38% of all cancer cases among the 0–19 year-old age group. Over 5,000 Australians die each year from blood cancers.1 NHMRC-funded researchers at WEHI have made revolutionary breakthroughs in our understanding of leukaemia biology, leading to the development of a new type of anti-cancer drug, venetoclax, that has significantly improved treatment for leukaemia patients.